Results 231 to 240 of about 103,807 (331)

Cerebral glucose metabolism and regional homogeneity as predictors of amyloid burden changes in preclinical AD

open access: yesAlzheimer's &Dementia, Volume 21, Issue S2, December 2025.
Abstract Background Regional homogeneity (ReHo) is a widely used measure in resting‐state functional magnetic resonance imaging (rs‐fMRI) for assessing the coherence of blood oxygen level‐dependent (BOLD) fMRI timeseries among contiguous brain regions.
Michalis Kassinopoulos   +14 more
wiley   +1 more source

Clinical Images: Pseudo‐pseudo Meigs syndrome

open access: yes
ACR Open Rheumatology, Volume 7, Issue 12, December 2025.
Ming‐Hsuan Tsai, Hsien‐Tzung Liao
wiley   +1 more source

Serum β‐Synuclein as a Potential Early Biomarker for Alzheimer's Disease

open access: yesAlzheimer's &Dementia, Volume 21, Issue S2, December 2025.
Abstract Background Alzheimer's disease (AD) is characterized by amyloid‐β (Aβ) plaques, neurofibrillary tangles, and synaptic dysfunction. The updated 2024 Alzheimer's Association criteria incorporate blood‐based biomarkers (BBMs) alongside traditional cerebrospinal fluid (CSF) and neuroimaging biomarkers, reflecting the growing importance of ...
Siqi Xie   +3 more
wiley   +1 more source

Esophageal Cancer With Neurologically Symptomatic Parapharyngeal Space Paraganglioma. [PDF]

open access: yesClin Case Rep
A case of advanced esophageal cancers complicated by a parapharyngeal space paraganglioma. MRI showed a right PPS tumor with characteristic imaging features, and endoscopy revealed advanced tumors in both the upper and lower esophagus. Radiotherapy for the paraganglioma followed by neoadjuvant chemotherapy and esophagectomy for the esophageal cancer ...
Nozu S   +5 more
europepmc   +2 more sources

Fluorodeoxyglucose-PET guided biopsy

open access: yesIndian Journal of Rheumatology, 2013
Babita Pangtey   +2 more
openaire   +1 more source

Predicting amyloid accumulation in subjects with cognitive disorders by using machine learning with 18F‐FDG‐PET images

open access: yesAlzheimer's &Dementia, Volume 21, Issue S2, December 2025.
Abstract Background Since the approval of disease‐modifying drugs for Alzheimer's disease, the demand for amyloid positron emission tomography (PET) scans, which are crucial for determining treatment eligibility, is expected to increase significantly.
Kazunari Ishii   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy